Skip to main content
OpenTrials

Clinical trial condition

Melanoma Stage III

Explore clinical trials studying Melanoma Stage III. Study availability and eligibility vary by location and protocol.

35 public trials 16 recruiting studies
Refine in advanced search Browse all conditions

Melanoma Stage III trial results

Recruiting

Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination With Pembrolizumab, in Unresectable Melanoma Patients

NCT06284590

Conditions
Melanoma, Melanoma Stage III, Melanoma Stage IV, +11 more
Locations
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Hartford Hospital Hartford, Connecticut, United States
  • Universitätsklinikum Essen Essen, Germany
  • University of Freiburg, Faculty of Medicine Freiburg im Breisgau, Germany
View Trial Details
Recruiting

The Efficacy and Safety of PRTX007-003 Combined With Pembrolizumab in Resectable Stage III Melanoma

NCT07565285

Conditions
Melanoma, Melanoma Stage III, Neoplasms, +10 more
Locations
  • Calvary Mater Newcastle Waratah, New South Wales, Australia
  • Gallipoli Medical Research Greenslopes, Queensland, Australia
  • Princess Alexandra Hospital Woolloongabba, Queensland, Australia
  • Peter MacCallum Cancer Centre Melbourne, Victoria, Australia
View Trial Details
Recruiting

MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma

NCT05655312

Conditions
Melanoma, Melanoma Stage III, Melanoma Stage IV, +13 more
Locations
  • University of California Irvine Orange, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • University of Miami Miami, Florida, United States
  • Sarasota Memorial Hospital Sarasota, Florida, United States
View all 13 locations
View Trial Details
Recruiting

Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies

NCT06508775

Conditions
Acute Lymphatic Leukemia, B-cell Non Hodgkin Lymphoma, Childhood Non-Hodgkin Lymphoma, +34 more
Locations
  • Charité Universitätsmedizin Berlin Berlin, Germany
  • Universitätsklinikum Köln Cologne, Germany
  • Uniklinikum Erlangen Erlangen, Germany
  • Universitätsmedizin Göttingen Göttingen, Germany
View Trial Details

Related conditions